2,2-difluorodioxolo A2A receptor antagonists
US-11046714-B2 · Jun 29, 2021 · US
This page is not indexed by search engines while we improve data quality.
Stamford Andrew patents
Stamford Andrew holds 14 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 14 |
| Recent patents | 0 |
| First publication | Apr 14, 2015 |
| Latest publication | Jun 29, 2021 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Processes for the preparation of a bace inhibitor
US-2017233382-A1 · Aug 17, 2017 · US
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties
US-9676780-B2 · Jun 13, 2017 · US
Bridged bicyclic piperidine derivatives and methods of use thereof
US-9409918-B2 · Aug 9, 2016 · US
2,2-difluorodioxolo a2a receptor antagonists
US-2016214997-A1 · Jul 28, 2016 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
2,2-difluorodioxolo A2A receptor antagonists
US-11046714-B2 · Jun 29, 2021 · US
Processes for the preparation of a bace inhibitor
US-2017233382-A1 · Aug 17, 2017 · US
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties
US-9676780-B2 · Jun 13, 2017 · US
Bridged bicyclic piperidine derivatives and methods of use thereof
US-9409918-B2 · Aug 9, 2016 · US
2,2-difluorodioxolo a2a receptor antagonists
US-2016214997-A1 · Jul 28, 2016 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 14 |
| Human Necessities | 13 |
| Cross-Sectional Technologies | 1 |